Skip to main content
Terug
Watch Compare

Tonix Pharmaceuticals Holding Corp.

Datakwaliteit: 100%
TNXP
Nasdaq Manufacturing Chemicals
€ 13,20
▲ € 0,16 (1,19%)
Marktkapitalisatie: 187,44 M
Prijs
€ 13,20
Marktkapitalisatie
187,44 M
Dagbereik
€ 12,90 — € 13,49
52-Weeksbereik
€ 11,60 — € 69,97
Volume
258.836
Openen € 13,03
50D / 200D Gem.
€ 15,02
12,18% below
50D / 200D Gem.
€ 24,05
45,14% below

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,04 — conservative balance sheet
Negative free cash flow of -103,21 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)29,85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-62,14%
Onder sectorgemiddelde (-53,47%)
ROIC-49,69%
Net Margin-946,22%
Op. Margin-959,05%

Veiligheid

Debt / Equity
0,04
Onder sectorgemiddelde (0,31)
Current Ratio9,89
Interest Coverage-1412,39

Waardering

PE (TTM)
-1,51
Onder sectorgemiddelde (-1,47)
P/B Ratio0,81
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -1,5 -1,5
P/B 0,8 1,6
ROE % -62,1 -53,5
Net Margin % -946,2 -41,5
Rev Growth 5Y % — 1,8
D/E 0,0 0,3

ETFs Holding This Stock

NOSGX NOSGX
0,20% weight
WINDX WINDX
0,03% weight
WFIVX WFIVX
0,03% weight
IRSSX IRSSX
0,01% weight
VVICX VVICX
0,01% weight
IIRSX IIRSX
0,01% weight
IRCIX IRCIX
0,01% weight
IRSIX IRSIX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 29,85% Revenue Growth (3Y) 29,90%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 13,11 M Net Income (TTM) -124,02 M
ROE -62,14% ROA -56,40%
Gross Margin N/A Operating Margin -959,05%
Net Margin -946,22% Free Cash Flow (TTM) -103,21 M
ROIC -49,69% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,04 Current Ratio 9,89
Interest Coverage -1412,39 Asset Turnover 0,06
Working Capital 187,04 M Tangible Book Value 231,02 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,51 Forward P/E N/A
P/B Ratio 0,81 P/S Ratio 14,30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -55,06%
Market Cap 187,44 M Enterprise Value 6,04 M
Per Share
EPS (Diluted TTM) -14,57 Revenue / Share 0,92
FCF / Share -7,27 OCF / Share -7,03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 25,70% FCF Conversion 83,22%
SBC-Adj. FCF -108,48 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13,11 M 10,09 M 7,77 M — —
Net Income -124,02 M -130,04 M -116,66 M -110,22 M -92,29 M
EPS (Diluted) -14,57 -176,60 -6,85 -3,27 —
Gross Profit — — — — —
Operating Income -125,70 M -136,70 M -118,38 M -112,09 M -92,31 M
EBITDA — — — — —
R&D Expenses 44,49 M 39,97 M 86,66 M 81,88 M 68,84 M
SG&A Expenses 87,68 M 40,10 M 34,75 M — —
D&A 1,93 M 3,42 M 4,29 M 1,25 M 50.000,0
Interest Expense 89.000,0 — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 277,17 M 162,89 M 154,46 M 225,69 M 240,90 M
Total Liabilities 32,02 M 23,33 M 48,93 M 18,51 M 22,18 M
Shareholders' Equity 245,15 M 139,56 M 105,53 M 207,18 M 218,72 M
Total Debt 8,65 M 8,65 M 11,00 M — —
Cash & Equivalents 207,64 M 98,78 M 24,95 M 120,23 M 178,66 M
Current Assets 228,88 M 119,00 M 47,77 M 130,78 M 189,05 M
Current Liabilities 30,84 M 18,31 M 18,88 M 18,18 M 21,72 M